What is Summit Therapeutics Inc.’s 1-month forecast?

Meyka AI projects SMMT could trade near $10.50 in the next month, a move of -34.21% compared to today’s price.

What is Summit Therapeutics Inc.’s 1-year forecast?

By 2027, SMMT is forecasted to reach $29.70, reflecting a 86.11% change from the current level.

What is Summit Therapeutics Inc.’s 5-year forecast?

The 2030 projection for SMMT is $58.93, which represents a potential 269.24% change.

What is the 7-year outlook for Summit Therapeutics Inc.?

Over the next 7 years, SMMT could trade around $73.92, showing a 363.13% move from today’s price.

Can Summit Therapeutics Inc. (SMMT) reach $75 by 2030?

Meyka AI’s 2030 forecast places SMMT at $58.93, making it unlikely to reach $75 by 2030 under current market conditions.

Summit Therapeutics Inc.

SMMT•NASDAQ

Healthcare

Biotechnology

$15.96

$0.09(0.57%)

U.S. Market is Open • 12:29

Summit Therapeutics Inc. (SMMT) Stock Forecast & Price Predictions

Get the latest Summit Therapeutics Inc. (SMMT) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price$10.50

Change↓ $-5.46 (-34.21%)

Quarterly Forecast

Predicted Price$11.27

Change↓ $-4.69 (-29.39%)

Yearly Forecast

Predicted Price$29.70

Change↑ $13.74 (86.11%)

3 Years Forecast

Predicted Price$44.33

Change↑ $28.37 (177.74%)

5 Years Forecast

Predicted Price$58.93

Change↑ $42.97 (269.24%)

7 Years Forecast

Predicted Price$73.92

Change↑ $57.96 (363.13%)

Summit Therapeutics Inc. Stock Forecast Summary

Summit Therapeutics Inc. (SMMT) stock is currently priced at $15.96. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $10.50.

In the long term, SMMT shows a bullish trend. The 2027 forecast points to $29.70 (86.11% change), while the 2031 forecast suggests $58.93 (269.24% change). Looking 7 years ahead, projections estimate the stock could trade near $73.92, a 363.13% change from today’s price.

Overall Sentiment

Neutral

Short-Term Outlook

Bearish

Long-Term Outlook

Bullish

This mix indicates that Summit Therapeutics Inc. stock is expected to rise steadily over the coming years.

Summit Therapeutics Inc. yearly Price Forecast Chart

Explore the yearly forecast chart for SMMT, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Summit Therapeutics Inc. over different timeframes.

No forecast data available

No prediction data found for this time period.

Forecasting data is not available for SMMTForecasting details for SMMT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Summit Therapeutics Inc. Stock Forecast 2026

The forecast for Summit Therapeutics Inc. (SMMT) in 2026 suggests a price of $29.70, representing a 86.11% move from today’s price.

Average Target: $29.70

Market Outlook: bullish based on current trend indicators.

Key Drivers in 2026:

Earnings growth projections.
Competitive performance in the Healthcare.
Macroeconomic factors such as interest rates and inflation.

Summit Therapeutics Inc. Stock Forecast 2030

By 2030, Meyka AI projects SMMT could trade near $58.93, showing a potential 269.24% compared to current levels.

Average Target: $58.93

Market Outlook: bullish.

What could influence the 2030 forecast:

Technological innovation and product cycles.
Expansion into global markets.
Long-term investor sentiment toward Summit Therapeutics Inc..

Summit Therapeutics Inc. 7-Year Stock Forecast (2032–2033)

Looking 7 years ahead, the long-term forecast for SMMT points to a price around $73.92, which is a projected 363.13% move from today’s level.

Average Target: $73.92

Outlook: bullish, depending on macroeconomic conditions and sector growth.

Long-Term Drivers:

Global economic expansion or contraction.
Regulatory and policy environment.
Summit Therapeutics Inc.’s ability to maintain market leadership.